Xia Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xia Li has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Anne B. Need
2 shared publicationsJeffrey M. Witkin
2 shared publicationsPhil Skolnick
DOV Pharmaceutical, Inc
2 shared publicationsJoseph P Tizzano
1 shared publicationKelly Griffey
1 shared publicationMelvyn Baez
1 shared publication
Latest Publications
- 1 October 2006
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 319 (1) , 254-259
Metabotropic Glutamate 5 Receptor Antagonism Is Associated with Antidepressant-Like Effects in Mice
Antidepressant-like effects of metabotropic glutamate (mGlu)5 receptor antagonists have been reported previously. We now provide definitive identification of mGlu5 receptors as a target for these effects through the combined use of selective antagonists and mice with targeted deletion of the mGlu5 protein. In these experiments, the mGlu5 receptor antagonists 2-methyl-6-(phenylethynyl)-pyridine (MPEP) and the more selective and metabolically stable analog 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP) decreased immobility in the mouse forced swim test, a test predictive of antidepressant efficacy in humans. mGlu5 receptor knockout mice had a phenotype in the forced swim test that was congruent with the effects of receptor blockade; mGlu5 receptor knockout mice were significantly less immobile than their wild-type counterparts. Consistent with mGlu5 receptor mediation of the antidepressant-like effects of MPEP, the effects of MPEP were not observed in mGlu5 receptor knockout mice, whereas comparable effects of the tricyclic antidepressant imiprimine remained active in the mutant mice. MPEP and imiprimine resulted in a synergistic antidepressant-like effect in the forced swim test. The drug interaction was not likely because of increased levels of drugs in the brain, suggesting a pharmacodynamic interaction of mGlu5 and monoaminergic systems in this effect. Thus, the present findings substantiate the hypothesis that mGlu5 receptor antagonism is associated with antidepressant-like effects. This mechanism may not only provide a novel approach to the therapeutic management of depressive disorders but also may be useful in the augmentation of effects of traditional antidepressant agents.
- 1 October 2006
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 319 (1) , 254-259
Metabotropic Glutamate 5 Receptor Antagonism Is Associated with Antidepressant-Like Effects in Mice
Antidepressant-like effects of metabotropic glutamate (mGlu)5 receptor antagonists have been reported previously. We now provide definitive identification of mGlu5 receptors as a target for these effects through the combined use of selective antagonists and mice with targeted deletion of the mGlu5 protein. In these experiments, the mGlu5 receptor antagonists 2-methyl-6-(phenylethynyl)-pyridine (MPEP) and the more selective and metabolically stable analog 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP) decreased immobility in the mouse forced swim test, a test predictive of antidepressant efficacy in humans. mGlu5 receptor knockout mice had a phenotype in the forced swim test that was congruent with the effects of receptor blockade; mGlu5 receptor knockout mice were significantly less immobile than their wild-type counterparts. Consistent with mGlu5 receptor mediation of the antidepressant-like effects of MPEP, the effects of MPEP were not observed in mGlu5 receptor knockout mice, whereas comparable effects of the tricyclic antidepressant imiprimine remained active in the mutant mice. MPEP and imiprimine resulted in a synergistic antidepressant-like effect in the forced swim test. The drug interaction was not likely because of increased levels of drugs in the brain, suggesting a pharmacodynamic interaction of mGlu5 and monoaminergic systems in this effect. Thus, the present findings substantiate the hypothesis that mGlu5 receptor antagonism is associated with antidepressant-like effects. This mechanism may not only provide a novel approach to the therapeutic management of depressive disorders but also may be useful in the augmentation of effects of traditional antidepressant agents.
- 1 June 2003
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 23 (3) , 419-430
Enhancement of Antidepressant Potency by a Potentiator of AMPA Receptors
1. AMPA receptor potentiators (ARPs) exhibit antidepressant-like activity in preclinical tests (for example, the forced swim test) that are highly predictive of efficacy in humans. Unlike most...
- 1 June 2003
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 23 (3) , 419-430
Enhancement of Antidepressant Potency by a Potentiator of AMPA Receptors
1. AMPA receptor potentiators (ARPs) exhibit antidepressant-like activity in preclinical tests (for example, the forced swim test) that are highly predictive of efficacy in humans. Unlike most...
- 1 June 2001
- Published by Elsevier in Neuropharmacology
- Vol. 40 (8) , 1028-1033
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
- 1 June 2001
- Published by Elsevier in Neuropharmacology
- Vol. 40 (8) , 1028-1033
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)